Research showed that many patients with skin cancer who had been treated using immunotherapy, such as immune checkpoint inhibition, experienced chronic side effects.
Cytrellis' new president and CEO discusses bridging surgery and innovation in aesthetics.
His keynote speech at ACMS focused on artificial intelligence for precision medicine and cancer diagnosis.
Anastasia Georgievskaya reflects on the success of SkinGPT and reveals upcoming plans and potential advancements in artificial intelligence and dermatology.
Wendy Smith Begolka, MBS, and Renata Block, MMS, PA-C discuss the NEA's expanded eczema visual guide and upcoming Chicago event to support diverse patient communities.
Gina Mangin, MPAS, PA-C, discusses how measuring atopic dermatitis treatment success requires evaluating multiple factors, including reduction in itch intensity, improvement in sleep quality, decreased flare frequency, enhanced quality of life, and visible skin healing through standardized assessment tools and patient-reported outcomes.
Jordan Bui and Bernard A. Cohen, MD, review a case of a young patient with vitiligo.
David Rosmarin, MD, shared his insights on the study in a Q&A with Dermatology Times.
Bradley Burnam discusses results from an in-vivo model of atopic dermatitis.
Earlier this summer, Meghan Heberton, MD, emphasized the importance and growth of the subspecialty.
UCSD's Clean Slate Program empowers medical students through hands-on experience in tattoo removal, enhancing community health and social justice initiatives.
Experts in the field share why they enjoyed the 5th Annual Revolutionizing Atopic Dermatitis Conference and why it is unique.
John Browning, MD, FAAD, FAAP, MBA, discusses the new online platform that allows young patients to share their skin journey with others.
Mickey Bryson describes the impact of atopic dermatitis on his quality of life and family, and the session concludes with final reflections.
Skin care for diabetes management focuses on prevention, routine inspections, and maintaining healthy skin to avoid complications.
Explore how BCs are supported through complex drug approvals and ensuring patients have access to prescribed medications.
A panelist discusses how laser treatments have evolved to effectively address diverse skin conditions and aesthetic concerns across different ethnicities, expanding access to personalized care options.
It is crucial to better understand, diagnose, and manage this skin condition associated with significant quality-of-life impairment.
Shannon Humphrey, MD, leads a shift in aesthetic dermatology towards patient empowerment and self-care, supported by Merz Aesthetics' Pillars of Confidence study.
Understanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.
Graber spoke with Dermatology Times to share the top clinical pearls and key takeaways from the recent meetings.
Robinson shared insights into how the company is working to fight clinical research disparities.
Sonya Kenkare, MD, explains her approach to itch and the support system of multiple specialties to help a pediatric patient with atopic dermatitis.
Frequent fliers, including pilots and cabin crew, are exposed to greater levels of UV and cosmic ionizing radiation than the general population, leading to higher incidence of skin cancers.